SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001193125-12-175932
Filing Date
2012-04-23
Accepted
2012-04-23 16:15:25
Documents
4
Effectiveness Date
2012-04-23

Document Format Files

Seq Description Document Type Size
1 REVISED DEFINITIVE PROXY STATEMENT d338634ddefr14a.htm DEFR14A 767015
2 GRAPHIC g338634cm1.jpg GRAPHIC 808
3 GRAPHIC g338634g92o25.jpg GRAPHIC 5358
4 GRAPHIC g338634pc_pg02.jpg GRAPHIC 1446
  Complete submission text file 0001193125-12-175932.txt   778963
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 000-24274 | Film No.: 12773491
SIC: 2836 Biological Products, (No Diagnostic Substances)